Dana-Farber Cancer Institute Hematology and Medical Oncology

Topics

• Lymphoma Diagnosis and Treatment 642
• Chronic Lymphocytic Leukemia Research 439
• Hematopoietic Stem Cell Transplantation 433
• Acute Myeloid Leukemia Research 414
• Tuberous Sclerosis Complex Research 306
• Multiple Myeloma Research and Treatments 291
• Lung Cancer Treatments and Mutations 263
• CAR-T cell therapy research 246
• Chronic Myeloid Leukemia Treatments 188
• Cancer Immunotherapy and Biomarkers 167
• Cancer survivorship and care 155
• Cancer Genomics and Diagnostics 144

Most cited

1. Post-acute COVID-19 syndrome.

   Nature medicine · 2021 · 3,389 citations · Jean Connors

2. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee.

   Blood · 2022 · 1,363 citations · Gilles Salles, Steven Treon, Ann LaCasce

3. Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma.

   The New England journal of medicine · 2021 · 2,130 citations · Noopur Raje

4. PD-1 Blockade in Mismatch Repair-Deficient, Locally Advanced Rectal Cancer.

   The New England journal of medicine · 2022 · 1,296 citations · Zsofia Stadler

5. MitoCarta3.0: an updated mitochondrial proteome now with sub-organelle localization and pathway annotations.

   Nucleic acids research · 2021 · 1,545 citations · Jordan Wengrod

6. Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma.

   The New England journal of medicine · 2022 · 793 citations ·